This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.

A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission

NCT03281304 ·Status: TERMINATED ·Phase: PHASE4

Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.

NCT05069259 ·Status: TERMINATED

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

NCT01465763 ·Status: COMPLETED ·Phase: PHASE3

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

NCT01458951 ·Status: COMPLETED ·Phase: PHASE3

Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis

NCT05112263 ·Status: NOT_YET_RECRUITING ·Phase: NA

Tofacitinib Registry of Patients With Ulcerative Colitis in Germany

NCT04032756 ·Status: TERMINATED

Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.

NCT05728008 ·Status: COMPLETED

Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?

NCT03011268 ·Status: COMPLETED ·Phase: NA

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

NCT02840721 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine

NCT06525974 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)

NCT07062185 ·Status: NOT_YET_RECRUITING ·Phase: NA

Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples

NCT03663400 ·Status: COMPLETED

Fecal Biomarker Study for Patients With Ulcerative Colitis

NCT00780507 ·Status: COMPLETED

A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03844932 ·Status: TERMINATED ·Phase: PHASE2

A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

NCT06865417 ·Status: RECRUITING ·Phase: PHASE3

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

NCT02914535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)

NCT01861249 ·Status: TERMINATED ·Phase: PHASE2

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis

NCT02888379 ·Status: COMPLETED ·Phase: PHASE2

A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

NCT05528510 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

NCT02914522 ·Status: COMPLETED ·Phase: PHASE3

Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

NCT00347048 ·Status: COMPLETED ·Phase: PHASE3

Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis

NCT03808506 ·Status: WITHDRAWN

Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis

NCT05496348 ·Status: RECRUITING

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

NCT01659138 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis

NCT00385736 ·Status: COMPLETED ·Phase: PHASE3